Domínguez-Comesaña E, Ballinas-Miranda JR

Idioma: Español
Referencias bibliográficas: 44
Paginas: 231-239
Archivo PDF: 338.52 Kb.

RESUMEN

Antecedentes: la procalcitonina es un marcador bastante específico de infección y en los últimos años se ha demostrado su superioridad, con respecto a otros marcadores de inflamación como la proteína C reactiva, para el diagnóstico y vigilancia de una gran variedad de infecciones.
Objetivo: resumir los datos actualmente existentes y discutir la utilidad de la procalcitonina en diversas infecciones intrabdominales, incluidas las postoperatorias.
Conclusiones: los resultados de estudios hasta ahora publicados son variables, lo que genera controversia en relación con su utilidad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Marshall JC. Principles of source control in the early management of sepsis. Curr Infect Dis Rep 2010;12:345-353.

2. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133-164.

3. O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from The American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008;36:1330-1349.

4. Moya F, Nieto A, Candela JLR. Calcitonin Byosinthesis: Evidence for a Precursor. Eur J Biochem 1975;55:407-413.

5. Maruna P, Nedêlníková K, Gürlich R. Physiology and Genetics of Procalcitonin. Physiol Res 2000;49(Suppl. 1):S57-S61.

6. Assicot M, Bohuon C, Gendrel D, Raymond J, Carsin H, Guilbaud J. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515- 518.

7. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-1608.

8. Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, et al. Serum proclacitonin elevation in critically ill patients at the onset of bacteriemia caused either gram negative or gram positive bacteria. BMC Infect Dis 2008;8:38-45. Disponible en http://www.biomedcentral.com/1471-2334/8/38

9. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-1 gen in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.

10. Matwiyoff GN, Prahl JD, Miller RJ, Carmichael JJ, Amundson DE, Seda G, et al. Immune regulation of procalctionin: a biomarker and mediator of infection. Inflamm Res 2012; 61:401-409.

11. Meisner M, Tschaikwosky K, Schnabel S, Schmidt J, Katalinic A, Schüttler J. Procalcitonin - Influence of Temperature, Storage, Anticoagulation and Arterial or Venous Asservation of Blood Samples on Procalcitonin Concentrations. Eur J Clin Chem Clin Biochem 1997;35:597-601.

12. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. Clin Infect Dis 2004;39:206-217.

13. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107-115. Disponible en http://www.biomedcentral.com/1741-7015/9/107.

14. Yu CW, Juan LI, Wu MH, Shen CJ, Wu JY, Lee CC. Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute apendicitis. Br J Surg 2013;100:322-329.

15. Ammori BJ, Becker KL, Kite P, Snider RH, Nylén ES, White JC, et al. Calcitonin Precursors: Early Markers of Gut Barrier Dysfunction in Patients With Acute Pancreatitis. Pancreas 2003;27:239-243.

16. Kylämpää-Bäck ML, Takala A, Kemppainen E, Puolakkainen P, Haapiainen R, Repo H. Procalcitonin strip test in early detection of severe acute pancreatitis. Br J Surg 2001;88:222-227.

17. Rau BM, Kemppainen EA, Gumbs AA, Büchler MW, Wegscheider K, Bassi C, et al. Early Assesment of Pancreatic Infections and Overall Prognosis in Severe Acute Pancreatitis by Procalcitonin (PCT). A Prospective Internatinal Multicenter Study. Ann Surg 2007;245:745-754.

18. Rau B, Pralle U, Mayer JM, Beger HG. Role of ultrasongraphically guided fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis. Br J Surg 1998;85:179-184.

19. Riché FC, Cholley BP, Laisné MJ, Vicaut E, Panis YH, Lajeunie EJ, et al. Inflammatory cytokines, C reactive protein and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery 2003;133:257-262.

20. Maruna P, Fraško R, Gürlich R. Plasma Procalcitonin in Patients with Ileus. Relations to Other Inflammatory Parameters. Physiol Res 2008;57:481-486.

21. Markogiannakis H, Memos N, Messaris E, Dardamanis D, Larentzakis A, Papanikolaou D, et al. Predictive value of procalcitonin for bowel ischemia and necrosis in bowel osbtruction. Surgery 2011;149:394-403.

22. Reith HB, Mittelkötter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000;26(Suppl 2):S165-S169.

23. Rau BM, Frigerio I, Büchler MW, Wegscheider K, Bassi C, Puolakkainen PA, et al. Evaluation of Procalcitonin for Predicting Septic Multiorgan Failure and Overall Prognosis in Secondary Peritonitis. Arch Surg 2007;142:134-142.

24. Viñas Trullen X, Rodríguez López R, Porta Pi S, Salazar Terceros D, Macarulla Sanz E, Besora Canal P, et al. Estudio prospectivo de la procalcitonina como marcador diagnóstico de gravedad en la peritonitis secundaria. Cir Esp 2009;86:24-28.

25. Novotny A, Emmanuel K, Matevossiam E, Kriner M, Ulm K, Bartels H, et al. Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 2007;194:35-39.

26. Novotny AR, Emmanuel K, Hueser N, Knebel C, Kriner M, Ulm K, et al. Procalcitonin ratio indicates successful of surgical treatment of abdominal sepsis. Surgery 2009;145:20- 26.

27. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998;24:680- 684.

28. Lindberg M, Åsberg A, Myrvold HE, Hole A, Rydning A, Bjerve KS. Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Invest 2002;62:189-194.

29. Molter GP, Soltész S, Kottke R, Wilhelm W, Biedler A, Silomom M. Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist 2003;52:210-217.

30. Di Filippo A, Lombardi A, Ognibene A, Messeri G, Tonelli F. Procalcitonin as an early marker of postoperative infectious complications. Minerva Chir 2002;57:59-62.

31. Sarbinowski R, Arvidsson S, Tylman M, Öresland T, Bengtsson A. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand 2005;49:191-196.

32. Reith HB, Mittelkötter U, Debus ES, Küssner C, Thiede A. Procalcitonin in Early Detection of Postoperative Complications. Dig Surg 1998;15:260-265.

33. Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkötter U. Pre-emptive antibiotic treatment vs ‘standard’ treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg 2006;391:187- 194.

34. Bianchi RA, Haedo AS, Romero MC. Papel de la determinación de procalcitonina plasmática en el seguimiento postoperatorio de la duodenopancreatectomía cefálica. Cir Esp 2006;79:356-360.

35. Siassi M, Riese J, Steffensen R, Meisner M, Thiel S, Hohenberger W, et al. Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care 2005;9:R483-489.

36. Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005;94:767-773.

37. Falcoz PE, Laluc F, Toubin MM, Puyraveau M, Clement F, Mercier M, et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg 2005;27:1074-1078.

38. Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B, Ferjani M. Assesment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac Surgery. Anesthesiology 2007;107:232-238.

39. Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011;105:1939-1945.

40. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients. A Randomized Trial. Am J Respir Crit Care Med 2008;177:498-505.

41. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin Algorithms for Antibiotic Therapy Decisions. A Systematic Review of Randomized Controlled Trials and Recommendations for Clinical Algorithms. Arch Intern Med 2011;171:1322-1331.

42. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012;73:221-227.

43. Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, et al. Procalcitonin to guide duration of antibioic theapy in intensive care patients: a randomized propspective controlled trial. Crit Care 2009;13:R83. Disponible en http://ccforum.com/content/13/3/R83

44. Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2009;394:221- 226.